Role of spinal microglia in rat models of peripheral nerve injury and inflammation

European Journal of Pain

Volumn 11, Issue 2, 2007, Pages 223-230

  Clark, Anna K ^a,b   Gentry, Clive ^b   Bradbury, Elizabeth J ^a   McMahon, Stephen B ^a   Malcangio, Marzia ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

CFA; Hyperalgesia; Neuropathy; OX42; Zymosan

Indexed keywords

FREUND ADJUVANT; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; HYPERALGESIA; INFLAMMATION; MALE; MICROGLIA; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; STATISTICAL SIGNIFICANCE;

ANIMALS; CITRATES; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERALGESIA; MALE; MICROGLIA; NEURITIS; PAIN THRESHOLD; POSTERIOR HORN CELLS; RATS; RATS, WISTAR; SCIATIC NERVE; SPINAL CORD; ZYMOSAN;

EID: 33751513963     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2006.02.003     Document Type: Article

References (38)

1. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. PNAS 100 (2003) 7947-7952
2. Araque A., Parpura V., Sanzgiri R.P., and Haydon P.G. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22 (1999) 208-215
3. Banati R.B., Cagnin A., Brooks D.J., Gunn R.N., Myers R., Jones T., et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport 12 (2001) 3439-3442
4. Chacur M., Gutierrez J.M., Milligan E.D., Wieseler-Frank J., Britto L.R.G., Maier S.F., et al. Snake venom components enhance pain upon subcutaneous injection: an initial examination of spinal cord mediators. Pain 111 (2004) 65-76
5. Chauvet N., Palin K., Verrier D., Poole S., Dantzer R., and Lestage J. Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide. Eur J Neurosci 14 (2001) 609-617
6. Coyle D.E. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 23 (1998) 75-83
7. Davies D.H., Halablab M.A., Clarke J., Cox F.E.G., and Young T.W.K. Infection and immunity (1998), Taylor & Francis, London (UK) 237 p.
8. DeLeo J.A., and Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90 (2001) 1-6
9. Freud J. Some aspects of active immunization. Annu Rev Microbiol 1 (1947) 291-308
10. Fu K.Y., Light A.R., and Maixner W. Relationship between nociceptor activity, peripheral edema, spinal microglial activation and long-term hyperalgesia induced by formalin. Neuroscience 101 (2000) 1127-1135
11. Fu K.Y., Light A.R., Matsushima G.K., and Maixner W. Microglial reactions after subcutaneous formalin injection into the rat hind paw. Brain Res 825 (1999) 59-67
12. Hashizume H., DeLeo J.A., Colburn R.W., and Weinstein J.N. Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 25 (2000) 1206-1217
13. Hassel B., Paulsen R.E., Johnsen A., and Fonnum F. Selective inhibition of glial cell metabolism in vivo by fluorocitrate. Brain Res 576 (1992) 120-124
14. Hua X.Y., Svensson C.I., Matsui T., Fitzsimmons B., Yaksh T.L., and Webb M. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur J Neurosci 22 (2005) 2431-2440
15. Ji R.R., and Rupp F. Phosphorylation of transcription factor CREB in rat spinal cord after formalin-induced hyperalgesia: relationship to c-fos induction. J Neurosci 17 (1997) 1776-1785
16. Joiner K.A., Brown E.J., and Frank M.M. Complement and bacteria: chemistry and biology in host defence. Annu Rev Immunol 2 (1984) 461-492
17. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115 (2005) 71-83
18. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nat Rev Neurosci 6 (2005) 521-532
19. McMahon S.B., Cafferty W.B.J., and Marchand F. Immune and glial cell factors as pain mediators and modulators. Exp Neurol 192 (2005) 444-462
20. Meller S.T., Dykstra C., Grzybycki D., Murphy S., and Gebhart G.F. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33 (1994) 1471-1478
21. Milligan E.D., Mehmert K.K., Hinde J.L., Harvey L.O., Martin D., Tracey K.J., et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res 861 (2000) 105-116
22. Milligan E.D., O'Connor K.A., Nguyen K.T., Armstrong C.B., Twining C., Gaykema R.P., et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 21 (2001) 2808-2819
23. Milligan E.D., Twining C., Chacur M., Biedenkapp J., O'Connor K., Poole S., et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23 (2003) 1026-1040
24. Pillemer L., and Ecker E.E. Anticomplementary factor in fresh yeast. J Biol Chem 137 (1941) 139-142
25. Raghavendra V., Tanga F., and DeLeo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306 (2003) 624-630
26. Raghavendra V., Tanga F., Rutkowski M.D., and DeLeo J.A. Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain 104 (2003) 655-664
27. Raghavendra V., Tanga F.Y., and DeLeo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20 (2004) 467-473
28. Rus H., and Niculescu F. The complement system in central nervous system diseases. Immunol Res 24 (2001) 79-86
29. Seltzer Z., Dubner R., and Shir Y. A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43 (1990) 205-218
30. Sweitzer S.M., Colburn R.W., Rutkowski M., and DeLeo J.A. Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat. Brain Res 829 (1999) 209-221
31. Sweitzer S.M., Schubert P., and DeLeo J.A. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 297 (2001) 1210-1217
32. Tanga F.Y., Raghavendra V., and DeLeo J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 45 (2004) 397-407
33. Tikka T.M., and Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-d-aspartate neurotoxicity by inhibiting microglia. J Immunol 166 (2001) 7527-7533
34. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
35. Tsuda M., Inoue K., and Salter M.W. Neuropathic pain and spinal microglia: a big problem from molecules in 'small' glia. Trends Neurosci 28 (2005) 101-107
36. Twining C.M., Sloane E.M., Schoeniger D.K., Milligan E.D., Martin D., Marsh H., et al. Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization. J Pain 6 (2005) 174-183
37. Watkins L.R., Martin D., Ulrich P., Tracey K.J., and Maier S.F. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71 (1997) 225-235
38. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2 (2003) 973-985